Home > Qtrly Results > ORCHID PHARMA

ORCHID PHARMA
Quarterly Results Analysis [Dec2023]

ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Quarterly Results

Consolidated Dec2023
Audited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
Audited
Revenues ₹221 Cr ₹199 Cr ₹183 Cr ₹210 Cr ₹160 Cr ₹165 Cr ₹131 Cr ₹178 Cr
Expenses ₹185 Cr ₹175 Cr ₹161 Cr ₹170 Cr ₹146 Cr ₹147 Cr ₹119 Cr ₹152 Cr
Operating Income ₹35 Cr ₹23 Cr ₹22 Cr ₹40 Cr ₹14 Cr ₹18 Cr ₹12 Cr ₹26 Cr
Other Income ₹8 Cr ₹8 Cr ₹2 Cr ₹2 Cr ₹9 Cr ₹6 Cr ₹3 Cr ₹2 Cr
Interest ₹4 Cr ₹4 Cr ₹6 Cr ₹7 Cr ₹8 Cr ₹9 Cr ₹8 Cr ₹4 Cr
Depreciation ₹9 Cr ₹8 Cr ₹8 Cr ₹7 Cr ₹8 Cr ₹18 Cr ₹22 Cr ₹27 Cr
Profit Before Tax ₹30 Cr ₹20 Cr ₹11 Cr ₹66 Cr ₹7 Cr ₹-3 Cr ₹-14 Cr ₹-4 Cr
Profit After Tax ₹30 Cr ₹20 Cr ₹11 Cr ₹66 Cr ₹7 Cr ₹-3 Cr ₹-14 Cr ₹-4 Cr
EPS ₹5.80 ₹3.90 ₹1.85 ₹14.49 ₹1.86 ₹-1.32 ₹-3.68 ₹-1.61
Industry Peers & Returns1W1M1Y
ORCHID PHARMA 8.6% -12.4% 175.7%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

ORCHID PHARMA Quarterly Revenues

Revenues
Q-o-Q

10.99 %

Y-o-Y

38.08 %

Quarters Revenues % Change
Dec2023 ₹221 Cr
10.99
Sep2023 ₹199 Cr
8.66
Jun2023 ₹183 Cr
-12.85
Mar2023 ₹210 Cr
31.39
Dec2022 ₹160 Cr
-3.32
Sep2022 ₹165 Cr
26.16
Jun2022 ₹131 Cr
-26.47
Mar2022 ₹178 Cr -

ORCHID PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

51.79 %

Y-o-Y

159.11 %

Quarters Operating Profit % Change
Dec2023 ₹35 Cr
51.79
Sep2023 ₹23 Cr
5.29
Jun2023 ₹22 Cr
-44.21
Mar2023 ₹40 Cr
190.58
Dec2022 ₹14 Cr
-23.37
Sep2022 ₹18 Cr
43.16
Jun2022 ₹12 Cr
-51.68
Mar2022 ₹26 Cr -
Operating Margins
Q-o-Q

36.74 %

Y-o-Y

87.60 %

Quarters Operating Margin% % Change
Dec2023 16.04%
36.74
Sep2023 11.73%
-3.14
Jun2023 12.11%
-35.96
Mar2023 18.91%
121.17
Dec2022 8.55%
-20.76
Sep2022 10.79%
13.58
Jun2022 9.5%
-34.30
Mar2022 14.46% -

ORCHID PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

50.78 %

Y-o-Y

348.75 %

Quarters Profit After Tax % Change
Dec2023 ₹30 Cr
50.78
Sep2023 ₹20 Cr
85.84
Jun2023 ₹11 Cr
-83.66
Mar2023 ₹66 Cr
879.95
Dec2022 ₹7 Cr
Positive
Sep2022 ₹-3 Cr
Negative
Jun2022 ₹-14 Cr
Negative
Mar2022 ₹-4 Cr -
PAT Margins
Q-o-Q

35.95 %

Y-o-Y

225.18 %

Quarters PAT Margin(%) % Change
Dec2023 13.69 %
35.95
Sep2023 10.07 %
70.97
Jun2023 5.89 %
-81.25
Mar2023 31.41 %
646.08
Dec2022 4.21 %
Positive
Sep2022 -2.01 %
Negative
Jun2022 -10.76 %
Negative
Mar2022 -2 % -

ORCHID PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

48.72 %

Y-o-Y

211.83 %

Quarters EPS % Change
Dec2023 ₹5.8
48.72
Sep2023 ₹3.9
110.81
Jun2023 ₹1.85
-87.23
Mar2023 ₹14.49
679.03
Dec2022 ₹1.86
Positive
Sep2022 ₹-1.32
Negative
Jun2022 ₹-3.68
Negative
Mar2022 ₹-1.61 -

You may also like the below Video Courses